What does the evidence say about Maca Sleep Quality Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Maca Sleep Quality Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Background : Atrial fibrillation (AF) significantly impacts the clinical and financial burden of healthcare systems worldwide. [Sokolova E (2026); evidence level 4] - Patient-reported outcomes (PROMs) are considered a core element of patient-centered care. [Sokolova E (2026); evidence level 4] - Under normal conditions, it is sequestered in the cytoplasm by Kelch-like ECH-associated protein 1 (Keap1), which targets it for degradation []. [Cipriano Giovanni Luca (2026); evidence level 4] - The following subsections provide a detailed analysis of the molecular profiles and clinical evidence for these three primary bioactives. [Cipriano Giovanni Luca (2026); evidence level 4] - In elderly patients with mild cognitive impairment (MCI), 16 weeks of Lion’s Mane supplementation significantly improved cognitive scores, with a subsequent decline observed once supplementation ceased, emphasizing its role in maintaining functional neural connectivity []. [Cipriano Giovanni Luca (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.